Middle East and Africa Ocular Drug Delivery Market
No. of Pages: 135 | Report Code: TIPRE00025782 | Category: Life Sciences
No. of Pages: 135 | Report Code: TIPRE00025782 | Category: Life Sciences
The Middle East & Africa ocular drug delivery market includes the consolidated markets for UAE, Saudi Arabia, South Africa and Rest of Middle East and Africa. The region occupies fourth position among the other region, the Saudi Arabia is the largest market in the Middle East & Africa region. The Saudi Arabia has made great strides in improving eye health. As per the WHO, around 8,000 children have functional low vision in Saudi Arabia. Congenital glaucoma is amongst the leading cause of childhood blindness in the country. Moreover, increasing use of computers and smartphones are creating demand for ocular pharmaceuticals during the forecast period. Prevention of blindness and deafness has been incorporated into Saudi Arabia’s new primary health care policy. To maintain a continuum of eye care, a 5-10-year programme that encompasses screening for Retinopathy of Prematurity (ROP), pre-school vision, diabetic retinopathy, glaucoma and cataract are being developed within existing health structures. The MOH is currently establishing four additional eye centres across the country to deliver these services. MOH has reactivated its Prevention of Blindness (PB) unit and moving operational responsibility to areas responsible for Public Health and non-communicable disease (NCDs). In 2013, approximately USD 2.66 million was allocated to blindness prevention specifically for diabetic retinopathy screening, the development of protocols for glaucoma, ROP and pre-school screening, and additional research.
The COVID-19 pandemic has become the most significant challenge in the region. Middle East countries have been registered a growth in the number of COVID cases. Many countries in the region have less developed and underfunded health systems. Apart from this, a huge population already face a growing burden of non-communicable diseases, making them more vulnerable to the virus. However, in view of the 'social distancing' requirements, many conferences across the globe have been cancelled or postponed. One of the largest ophthalmic conferences, the World Ophthalmic Congress, which was supposed to be held in Cape Town, South Africa has gone completely online with a virtual conference. These factors are expected to negatively impact the growth of the ocular drug delivery market in the region for short terms. However, as the vaccination progresses, and pandemic situation is under control the region will offer several growth prospects for the market player in ocular drug delivery market.
Strategic insights for the Middle East and Africa Ocular Drug Delivery provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1,272.46 Million |
| Market Size by 2028 | US$ 830.88 Million |
| Global CAGR (2021 - 2028) | 6.3% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered | Middle East and Africa
|
| Market leaders and key company profiles |
The geographic scope of the Middle East and Africa Ocular Drug Delivery refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The ocular drug delivery market in Middle East & Africa is expected to grow US$ 830.88 million by 2028 from US$ 1,272.46 million in 2021. The market is estimated to grow at a CAGR of 6.3% from 2021 to 2028. The incidence of eye diseases has increased significantly. In recent years, various measures and efforts have been taken to create awareness and educate people regarding eye diseases, facilitating patients access to suitable medications and treatments for such conditions. Sightsavers is an international non-governmental organization—works in developing countries to treat and prevent eye diseases. A large population of India resides in rural areas, which has limited or no awareness about eye ailments. With its Rural Eye Health Programme, Sightsavers aims to create awareness, provide high-quality eye health services, and eradicate avoidable blindness in the rural population. Thus, the growing eye health awareness programs are likely to create growth opportunities for the market.
Middle East & Africa ocular drug delivery market is segmented based on technology, formulation type, disease type, end user. Based on technology, the implantable ocular drug delivery systems segment accounted for the highest share in 2021. Based on formulation type, the solution segment accounted for the highest share in 2021. Based on disease type, the cataract segment accounted for the highest share in 2021. Based on end user hospitals segment accounted for the highest share in 2021.
A few major primary and secondary sources referred to for preparing this report on ocular drug delivery market in Middle East & Africa are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are AbbVie Inc.; Bausch Health Companies Inc.; Novartis AG; Clearside Biomedical, Inc.; Alimera Sciences, Inc. among others.
The Middle East and Africa Ocular Drug Delivery Market is valued at US$ 1,272.46 Million in 2021, it is projected to reach US$ 830.88 Million by 2028.
As per our report Middle East and Africa Ocular Drug Delivery Market, the market size is valued at US$ 1,272.46 Million in 2021, projecting it to reach US$ 830.88 Million by 2028. This translates to a CAGR of approximately 6.3% during the forecast period.
The Middle East and Africa Ocular Drug Delivery Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Ocular Drug Delivery Market report:
The Middle East and Africa Ocular Drug Delivery Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Ocular Drug Delivery Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Ocular Drug Delivery Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Ocular Drug Delivery Market
